Respuesta :
Answer:
Option 1, has type 2 diabetes
Explanation:
Patients with type 1 diabetes mellitus (T1DM) are insulin dependent -- that is, the beta cells within their pancreas cannot produce its own insulin in order to regulate the metabolism of glucose in the blood. Because of this, these patients must be given exogenous insulin, administered via a needle injection into subcutaneous tissues. At current, there are no oral insulins that are proven as effective at achieving glycemic control like injectable insulins, though there are animal trials due to start in 2025.
Oral antidiabetic medications are, however, effective at treating patients with type 2 diabetes mellitus (T2DM) -- or insulin-resistant diabetes -- as well as patients diagnosed with prediabetic status. Oral medications like metformin or dapagliflozin (brand name Farxiga) can help these patients by reducing the glucose absorption in the intestines, allowing for improvement of their insulin sensitivity. Patients living with T1DM, unfortunately, cannot benefit from these, because again, they do not produce insulin as is for there to be any improvement in sensitivity.
Therefore, the nurse should educate the patient that these medication are effective only if the client has type 2 diabetes, option 1. They should, though, inform their client about what may possibly be coming sometime down the line.
Oral antidiabetic agents are effective mainly for clients with type 2 diabetes because these drugs require the presence of insulin production, which is absent in type 1 diabetes. Therefore, the correct answer is option 1) has type 2 diabetes
A client with type 1 diabetes inquiring about the efficacy of oral antidiabetic agents would be informed by the nurse that these medications are typically effective only if the client has type 2 diabetes. This is because individuals with type 1 diabetes do not produce insulin, whereas type 2 diabetics may still produce insulin but their bodies do not use it properly due to defective insulin receptors or a lack of insulin receptors on target cells. Oral antidiabetic drugs, such as glyburide, stimulate the islet cells to secrete insulin and increase the sensitivity of cell receptors to insulin, helping patients with type 2 diabetes manage their blood sugar levels. However, proper blood sugar control requires careful monitoring and may necessitate adjustments in diet or the addition of medications.
